BriaCell reschedules Annual General Meeting of Shareholders to February 5 due to postal disruptions

From GlobeNewswire: 2025-01-03 17:05:00

BriaCell Therapeutics Corp. reschedules its Annual General Meeting of Shareholders from January 23, 2025, to February 5, 2025, due to postal service disruptions in Canada. Shareholders who have already voted need not take action, and votes will be counted at the postponed meeting. The Company urges shareholders who have not voted to do so by February 3, 2025. The Company filed its Proxy Statement on December 17, 2024, available on EDGAR, SEDAR+, and the Company’s website. The Meeting will address financial statements, director elections, auditor appointment, and ISS recommends voting FOR the proposals. Shareholders can vote by telephone, internet, or mail.

Registered shareholders can call Computershare at 1-800-564-6253 for voting control numbers. Beneficial shareholders can submit votes by completing the Voting Instruction Form and sending it to Computershare. Shareholders are encouraged to vote via telephone or internet. Shareholders with voting questions can contact BriaCell’s proxy solicitation agent, Sodali. BriaCell Therapeutics Corp. develops immunotherapies for cancer care. The Company’s forward-looking statements are subject to risks and uncertainties and should be read in conjunction with regulatory filings. The Toronto Stock Exchange does not assume responsibility for the release’s accuracy. For more information, contact William V. Williams, MD, President & CEO at 1-888-485-6340 or [email protected]. Media Relations: Jules Abraham at CORE IR, [email protected]. Investor Relations Contact: [email protected].



Read more at GlobeNewswire: BriaCell Announces Rescheduling of its Annual General